-
Mashup Score: 0The Cancer News Daily - 1 year(s) ago
The latest in cancer medicine and translational research by Wafik El-Deiry MDPhD
Source: paper.liCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Source: link.springer.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Prognostic Utility of Systemic Immune-Inflammation Index After Resection of #Extrahepatic #Cholangiocarcinoma : Results from the U.S. Extrahepatic #Biliary Malignancy Consortium https://t.co/KqAKMJMzQs @timpawlik @OSUWexMed #VisualAbstract @McMastersKelly https://t.co/tAgyFmcBcU
-
-
Mashup Score: 4Post-Transplantation Cytomegalovirus Infection Interplays With the Development of Anastomotic Biliary Strictures After Liver Transplantation - 2 year(s) ago
Background: Anastomotic biliary stricture (ABS) remains the most frequent complication after liver transplantation (LT). This study aimed to identify new anastomotic biliary stricture risk factors, with a specific focus on postoperative events. Additionally, ABS management and impact on patient and graft survival were assessed.Methods: All consecutive patients who underwent LT with duct-to-duct…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
#Biliary #stricture risk after #LiverTransplant is multifactorial, although events such as #CMV infection, and postoperative biliary #fistula are the main causes. Management is generally endoscopic and does not seem to impact on survival @ChirDigBesancon https://t.co/RhkFZIPaEG https://t.co/yz6dif0OFU
-
-
Mashup Score: 0Biliary Viability Assessment and Treatment Options of Biliary Injury During Normothermic Liver Perfusion—A Systematic Review - 2 year(s) ago
In recent years, significant progress has been made in the field of liver machine perfusion. Many large transplant centers have implemented machine perfusion strategies in their clinical routine. Normothermic machine perfusion (NMP) is primarily used to determine the quality of extended criteria donor (ECD) organs and for logistical reasons. The vast majority of studies, which assessed the…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
Take a look also at Biliary #Viability #Assessment and Treatment Options of #Biliary Injury During #Normothermic #Liver #Perfusion - A Systematic Review 🔗https://t.co/XgbtEgnxgi, to compare in situ versus ex-vivo technology. From the same Special Issue 👉 https://t.co/BBo2Qad36H https://t.co/hQeHVRvhnG
-
-
Mashup Score: 0Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation - 2 year(s) ago
Background: This study evaluated endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic biliary drainage (PTBD) as interventions for patients with anastomotic biliary complications (ABC) after living donor liver transplantation (LDLT).Methods: Prospectively collected data of patients who were diagnosed with ABC after LDLT between January 2013 and June 2017 were…
Source: FrontiersCategories: Latest Headlines, TransplantationTweet-
#ERCP versus #percutaneous transhepatic #biliary #drainage to treat anastomotic complications after #Living #Donor #LiverTransplant: recommendations for an optimal Intervention and initial treatment https://t.co/4TRyDxj6kB
-
-
Mashup Score: 3How I treat biliary tract cancer - 2 year(s) ago
Management of biliary tract cancers (BTCs) is rapidly evolving. Curative management relies on surgical resection followed by adjuvant capecitabine for cholangiocarcinoma and gallbladder cancers. Unfortunately relapse rate remains high, and better adjuvant strategies are urgently required. A majority of patients are diagnosed with advanced disease, when chemotherapy with cisplatin and gemcitabine…
Source: Esmo OpenCategories: Hem/Oncs, Latest HeadlinesTweet-
How I treat #biliary tract #cancer - an addition to the art in #cancertherapy series. Just published in @ESMO_Open by @myESMO https://t.co/Xfsoe3SVjf
-
-
Mashup Score: 0
We aimed to investigate the role of percutaneous biliary interventions in the management of biliary complicaitons in donors after living donor liver transplantation.
Source: Wiley Online LibraryCategories: Latest Headlines, TransplantationTweet-
#Percutaneous #biliary #interventions in the management of complications in #Living #Liver #Donors could eliminate the need for surgery or can guide surgical treatment https://t.co/qju0CF7uHn https://t.co/dSv1cIR2lE
-
-
Mashup Score: 1
Adding liposomal irinotecan to fluorouracil and leucovorin significantly improved BICR-assessed progression-free survival in patients with advanced biliary tract cancer. Liposomal irinotecan plus fluorouracil and leucovorin could be considered a standard-of-care second-line therapy for advanced biliary tract cancer.
Source: The Lancet OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Also in the Nov issue: NIFTY trial of liposomal #irinotecan plus #fluorouracil and leucovorin versus fluorouracil and leucovorin for #metastatic #biliary tract #cancer https://t.co/uCWMFPSlh5
-
-
Mashup Score: 1A systematic review and meta‐analyses of regional perfusion in donation after circulatory death solid organ transplantation - 2 year(s) ago
This systematic review and meta-analyses summarizes all available evidence on regional perfusion in donation after circulatory death donors. It found that regional perfusion is feasible and safe and …
Source: Wiley Online LibraryCategories: Latest Headlines, TransplantationTweet-
Meta-analyses on #NRP in #DCD, a safe and feasible technique, improving post-transplant outcomes, especially #biliary #complications, compared to ISP. @ijochmans @hessheimer @watsoncje @mirenebellini1 @ArneNeyrinck @DavidHealth5 @lisetpengel @transplantev https://t.co/1mLEfetjBc https://t.co/Zgsbu9X0lX
-
-
Mashup Score: 1Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study - 3 year(s) ago
PURPOSE Whether triplet chemotherapy is superior to doublet chemotherapy in advanced biliary tract cancer (BTC) is unknown. METHODS In this open-label, randomized phase II-III study, patients with locally advanced or metastatic BTC and an Eastern Cooperative Oncology Group performance status of 0 or 1 were randomly assigned (1:1) to receive oxaliplatin, irinotecan, and infusional fluorouracil…
Source: Journal of Clinical OncologyCategories: Latest Headlines, Oncologists1Tweet-
🙋♂️to my #GI #oncologists colleagues ➡️ I used to think it is ok to use FOLFOX instead of GEM/CIS as first line in #biliary #cancer…giving the result of PRODIGE 38 AMEBICA… FOLFOX should not be used as 1st line anymore? #medtwitter @OncoAlert https://t.co/EDmbOWHx7d
-
The latest The Cancer News Daily! https://t.co/x6JuFkM5BE Thanks to @DukeCancer @FDAOncology @TheCancerLetter #biliary #cancer